CSL300_2301_Ph3 12+
ERT,INC
-
- Free
Screenshots
Description
CSL Behring eCOA App is intended for use to collect patient reported outcomes relating to the CSL300_2301 Phase 3 Clinical Trial
The CSL Behring CSL300_2301 Phase 3 App is intended for use to collect patient reported outcomes relating to the CSL300_2301 Phase 3 clinical trial. Patients must be given accounts by a participating site in order to log in to the app
What’s New
Version 2.15.4 (13)
Language Batch 3
App Privacy
The developer, ERT,INC, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy.
Data Not Linked to You
The following data may be collected but it is not linked to your identity:
- Health & Fitness
Privacy practices may vary based on, for example, the features you use or your age. Learn More
Information
- Provider
- ERT, INC has not identified itself as a trader for this app. If you are a consumer in the European Economic Area, consumer rights do not apply to agreements between you and the provider.
- Size
- 79.6 MB
- Category
- Medical
- Compatibility
-
- iPhone
- Requires iOS 12.0 or later.
- iPad
- Requires iPadOS 12.0 or later.
- iPod touch
- Requires iOS 12.0 or later.
- Apple Vision
- Requires visionOS 1.0 or later.
- Languages
-
English
- Age Rating
- 12+ Infrequent/Mild Medical/Treatment Information
- Copyright
- © 2023 Clario, CSL Behring
- Price
- Free